SynteractHCR hires Bill Pierce and Richard Paul
Thursday, April 4, 2013
SynteractHCR, a full-service CRO, has hired two new senior executives to support the company’s growth on a global scale following its recent merger. SynteractHCR has appointed Bill Pierce as chief information officer and Richard Paul as chief medical officer and vice president medical/regulatory affairs.
As CIO, Pierce will be responsible for driving operational excellence, streamlining processes and delivering high returns for invested capital. He brings a strong foundation in the CRO industry and is very experienced across clinical data management platforms and technologies. He gained leadership experience across various industries, including his last position at INC Research as chief information officer. Previously, Pierce served as vice president both for Fidelity Investments and Goldman Sachs, among other leadership positions.
In his role as CMO, he will provide global leadership and oversight for medical safety and regulatory affairs. He brings more than 23 years of clinical research, regulatory affairs, medical safety and strategic drug development experience to his new role. Prior to joining SynteractHCR, Paul held positions with QRxPharma as executive vice president of drug development where he had global responsibility for clinical research and regulatory affairs. He also served as senior vice president of global regulatory affairs at Icon Clinical Research.